218 related articles for article (PubMed ID: 21705666)
1. Occupancy of both sites on the thyrotropin (TSH) receptor dimer is necessary for phosphoinositide signaling.
Allen MD; Neumann S; Gershengorn MC
FASEB J; 2011 Oct; 25(10):3687-94. PubMed ID: 21705666
[TBL] [Abstract][Full Text] [Related]
2. Thyrotropin receptor stimulates internalization-independent persistent phosphoinositide signaling.
Boutin A; Allen MD; Geras-Raaka E; Huang W; Neumann S; Gershengorn MC
Mol Pharmacol; 2011 Aug; 80(2):240-6. PubMed ID: 21525174
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule thyrotropin receptor agonist activates naturally occurring thyrotropin-insensitive mutants and reveals their distinct cyclic adenosine monophosphate signal persistence.
Allen MD; Neumann S; Gershengorn MC
Thyroid; 2011 Aug; 21(8):907-12. PubMed ID: 21745101
[TBL] [Abstract][Full Text] [Related]
4. Thyrotropin Causes Dose-dependent Biphasic Regulation of cAMP Production Mediated by G
Neumann S; Malik SS; Marcus-Samuels B; Eliseeva E; Jang D; Klubo-Gwiezdzinska J; Krieger CC; Gershengorn MC
Mol Pharmacol; 2020 Jan; 97(1):2-8. PubMed ID: 31704717
[TBL] [Abstract][Full Text] [Related]
5. TSH Receptor Homodimerization in Regulation of cAMP Production in Human Thyrocytes
Boutin A; Krieger CC; Marcus-Samuels B; Klubo-Gwiezdzinska J; Neumann S; Gershengorn MC
Front Endocrinol (Lausanne); 2020; 11():276. PubMed ID: 32425890
[TBL] [Abstract][Full Text] [Related]
6. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
7. Persistent cAMP signaling by thyrotropin (TSH) receptors is not dependent on internalization.
Neumann S; Geras-Raaka E; Marcus-Samuels B; Gershengorn MC
FASEB J; 2010 Oct; 24(10):3992-9. PubMed ID: 20538910
[TBL] [Abstract][Full Text] [Related]
8. Persistent cAMP signaling by TSH receptors revealed by phosphodiesterase inhibition.
Geras-Raaka E; Neumann S; Gershengorn MC
Thyroid; 2013 Nov; 23(11):1484-9. PubMed ID: 23713896
[TBL] [Abstract][Full Text] [Related]
9. Persistent cAMP signaling by internalized TSH receptors occurs in thyroid but not in HEK293 cells.
Werthmann RC; Volpe S; Lohse MJ; Calebiro D
FASEB J; 2012 May; 26(5):2043-8. PubMed ID: 22291442
[TBL] [Abstract][Full Text] [Related]
10. Expression of G(alpha)(s) proteins and TSH receptor signalling in hyperfunctioning thyroid nodules with TSH receptor mutations.
Holzapfel HP; Bergner B; Wonerow P; Paschke R
Eur J Endocrinol; 2002 Jul; 147(1):109-16. PubMed ID: 12088927
[TBL] [Abstract][Full Text] [Related]
11. TSH induces metallothionein 1 in thyrocytes via Gq/11- and PKC-dependent signaling.
Bäck CM; Stohr S; Schäfer EA; Biebermann H; Boekhoff I; Breit A; Gudermann T; Büch TR
J Mol Endocrinol; 2013; 51(1):79-90. PubMed ID: 23613280
[TBL] [Abstract][Full Text] [Related]
12. Subunit interactions influence TSHR multimerization.
Latif R; Michalek K; Davies TF
Mol Endocrinol; 2010 Oct; 24(10):2009-18. PubMed ID: 20719860
[TBL] [Abstract][Full Text] [Related]
13. Cysteine-699, a possible palmitoylation site of the thyrotropin receptor, is not crucial for cAMP or phosphoinositide signaling but is necessary for full surface expression.
Kosugi S; Mori T
Biochem Biophys Res Commun; 1996 Apr; 221(3):636-40. PubMed ID: 8630013
[TBL] [Abstract][Full Text] [Related]
14. Exosomes Expressing Thyrotropin Receptor Attenuate Autoantibody-Mediated Stimulation of Cyclic Adenosine Monophosphate Production.
Edo N; Kawakami K; Fujita Y; Morita K; Uno K; Tsukamoto K; Onose H; Ishikawa T; Ito M
Thyroid; 2019 Jul; 29(7):1012-1017. PubMed ID: 31062662
[No Abstract] [Full Text] [Related]
15. The Pathogenic TSH β-subunit Variant C105Vfs114X Causes a Modified Signaling Profile at TSHR.
Kalveram L; Kleinau G; Szymańska K; Scheerer P; Rivero-Müller A; Grüters-Kieslich A; Biebermann H
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31703413
[TBL] [Abstract][Full Text] [Related]
16. Suppression of thyrotropin receptor-G protein-phospholipase C coupling by activation of protein kinase C in thyroid carcinoma cells.
Broecker M; Mayr GW; Derwahl M
Endocrinology; 1997 Sep; 138(9):3787-96. PubMed ID: 9275066
[TBL] [Abstract][Full Text] [Related]
17. The middle portion in the second cytoplasmic loop of the thyrotropin receptor plays a crucial role in adenylate cyclase activation.
Kosugi S; Kohn LD; Akamizu T; Mori T
Mol Endocrinol; 1994 Apr; 8(4):498-509. PubMed ID: 7914349
[TBL] [Abstract][Full Text] [Related]
18. Structural determinants for G-protein activation and specificity in the third intracellular loop of the thyroid-stimulating hormone receptor.
Claus M; Neumann S; Kleinau G; Krause G; Paschke R
J Mol Med (Berl); 2006 Nov; 84(11):943-54. PubMed ID: 16955277
[TBL] [Abstract][Full Text] [Related]
19. Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor.
Latif R; Graves P; Davies TF
J Biol Chem; 2002 Nov; 277(47):45059-67. PubMed ID: 12223484
[TBL] [Abstract][Full Text] [Related]
20. Nonclassic TSH resistance: TSHR mutation carriers with discrepantly high thyroidal iodine uptake.
Narumi S; Nagasaki K; Ishii T; Muroya K; Asakura Y; Adachi M; Hasegawa T
J Clin Endocrinol Metab; 2011 Aug; 96(8):E1340-5. PubMed ID: 21677043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
